Clinical Research Directory
Browse clinical research sites, groups, and studies.
SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)
Sponsor: Istanbul University - Cerrahpasa
Summary
The goal of this clinical trial is to investigate the role of segmentectomy in clinical T1c (2-3 cm) non-small cell lung cancer (NSCLC). The main questions we aim to answer are: 1. Is segmentectomy non-inferior to lobectomy in cT1c NSCLC in terms of overall and recurrence free survival? 2. What are the mortality and morbidity rates of segmentectomy compared to lobectomy? Researchers will compare segmentectomy and lobectomy in terms of overall and recurrence free survival. Participants will: * Undergo either pulmonary lobectomy or segmentectomy with mediastinal nodal dissection * Be followed up with a chest CT in every 3 months in first year, every 6 months in second year and every year for following 3 years
Official title: Segmentectomy Versus Lobectomy in Clinical T1c Non-Small Cell Lung Cancer: A Non-Inferiority Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2025-01-02
Completion Date
2030-01
Last Updated
2024-10-17
Healthy Volunteers
No
Conditions
Interventions
Segmentectomy
Pulmonary anatomic segmentectomy with mediastinal nodal dissection via VATS, RATS or open approach.
Lobectomy
Pulmonary lobectomy with mediastinal nodal dissection via VATS, RATS or open approach.
Locations (1)
Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye)